A guide to prenatal counseling regarding neurodevelopment in congenital heart disease

Fu-Tsuen Lee1,2,3, Liqun Sun1,2, Lindsay Freud1,2

  • 1Division of Cardiology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Prenatal Diagnosis
|December 28, 2022
PubMed

Insights

Children with congenital heart disease often face neurodevelopmental challenges after infant cardiac repair. Prenatal counseling should address these potential learning disabilities and attention deficits, balancing risks with improved survival outcomes.

Area of Science:

  • Pediatric Cardiology
  • Neurodevelopmental Pediatrics
  • Congenital Heart Disease Research

Background:

  • Advances in cardiac surgery have increased survival rates for children with congenital heart defects into adulthood.
  • A significant number of patients experience adverse neurodevelopmental outcomes following infant cardiac repair.
  • The causes of abnormal brain development in congenital heart disease are complex and not fully understood.

Purpose of the Study:

  • To review neurodevelopmental outcomes in patients with congenital heart disease.
  • To explore approaches for communicating potential neurodevelopmental issues to parents during prenatal counseling.
  • To provide an up-to-date overview of the challenges and uncertainties in predicting neurodevelopmental trajectories.

Main Methods:

  • Literature review of neurodevelopmental outcomes in congenital heart disease.
  • Analysis of current prenatal counseling practices for congenital heart defects.
  • Synthesis of information on the etiology and management of neurodevelopmental deficits.

Main Results:

  • Infant cardiac repair is associated with a notable proportion of adverse neurodevelopmental outcomes.
  • Current antenatal testing offers limited prognostic information on neurodevelopmental trajectories.
  • The efficacy of therapies for neurodevelopmental deficits in this population remains uncertain.

Conclusions:

  • Prenatal counseling for congenital heart disease must inform parents about potential neurodevelopmental issues.
  • Counseling should convey uncertainties in predicting developmental disorders while highlighting improved survival.
  • A balanced approach includes discussing available neurodevelopmental follow-up arrangements.

Related Concept Videos

Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
26
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
30
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
27
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
30
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
25